Clinical Study
Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
Table 2
Univariate analysis of overall survival for clinicopathological parameters.
| Clinicopathological features | Hazard ratio (HR) | 95% CI for HR | value | Lower | Upper |
| Age (<55 versus ≥55) | 0.84 | 0.54 | 1.27 | 0.3943 | Gender (Male versus Female) | 1.18 | 0.70 | 1.94 | 0.5317 | HBV infection ((−) versus (+)) | 1.14 | 0.75 | 1.75 | 0.5403 | HCV infection ((−) versus (+)) | 0.89 | 0.57 | 1.41 | 0.6468 | AFP (<200 ng/mL versus >200 ng/mL) | 1.93 | 1.16 | 3.20 | 0.0031 | CA19-9 (≤27 U/mL versus >27 U/mL) | 1.87 | 1.21 | 2.90 | 0.0020 | Grade (1, 2 versus 3, 4) | 2.16 | 1.39 | 3.34 | 0.0001 | Size (<5 cm versus ≥5 cm) | 2.04 | 1.33 | 3.13 | 0.0004 | Vascular invasion ((−) versus (+)) | 1.70 | 1.09 | 2.66 | 0.0094 | Multiple ((−) versus (+)) | 1.79 | 1.11 | 2.87 | 0.0060 | Stage (I versus II, III) | 1.76 | 1.17 | 2.65 | 0.0057 |
|
|